Board Resolution Appointing Gabriel Yariv as Executive Chair of Cannabics Pharmaceuticals Inc.

Contract Categories: Business Operations › Administration Agreements
Summary

Cannabics Pharmaceuticals Inc.'s Board of Directors held a special meeting on September 3, 2021, where they unanimously resolved to appoint Gabriel Yariv as the Executive Chair of the company. Mr. Yariv will continue to serve as both a Director and Chief Operational Executive in addition to his new role. The resolution was formally adopted and recorded in the company's official records.

Read More Arrow
EX-10.1 2 cannabics_8k-ex1001.htm BOARD OF DIRECTOR'S RESOLUTION APPOINTING GABRIEL YARIV AS CHAIR

Exhibit 10.1

 

THE BOARD OF DIRECTORS

 

OF

 

CANNABICS PHARMACEUTICALS INC.

 

 

The following is a true copy of the resolution duly adopted by the Board of Directors of this Corporation at a special meeting, notice to this meeting having been waived, held on this 3rd day of September, 2021;

 

The Board of Directors which was present for this meeting & took active part therein was:

 

Eyal Barad

Gabriel Yariv

Gil Feiler

Dr. Inbar Maymon Pomeranchik

 

WHEREAS the Board of the Company decided to create the position of Executive Chair,

 

NOW THEREFORE BE IT RESOLVED that the majority of Directors having considered this matter, and having opened the floor to all those who voice a preference in the issue and pursuant to NRS 78.315, have unanimously decided and RESOLVED that:

 

GABRIEL YARIV shall retain his position as Director, and Chief Operational Executive, as well as now being the Executive Chair of the Company.

 

Said Motion is hereby passed and the corporate books, records and the Secretary shall file this Resolution in the corporate records

 

 

DATED: 3rd September, 2021

 

 

/s/ David E. Price                                      

David E. Price, Secretary, Corp Counsel